Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical Trials
NCT04242446 ( https://clinicaltrials.gov/study/NCT04242446 ); NCT04242498 ( https://clinicaltrials.gov/study/NCT04242498 ). An Infographic is available for this article. Infographic.
Authors
- Vivian Yan Shi (ORCID: https://orcid.org/0000-0002-7510-9428)
- Christopher J. Sayed (ORCID: https://orcid.org/0000-0003-3201-4637)
- Lauren A.V. Orenstein (ORCID: https://orcid.org/0000-0003-0534-2854)
- Leah Davis (ORCID: https://orcid.org/0000-0002-5409-620X)
- Robert Rolleri
- John W. Frew (ORCID: https://orcid.org/0000-0001-5042-3632)
- John R Ingram (ORCID: https://orcid.org/0000-0002-5257-1142)
- Jérémy Lambert (ORCID: https://orcid.org/0000-0002-7164-1492)
- Errol Prospero Prens (ORCID: https://orcid.org/0000-0002-8158-660X)
- Jacek Cezary Szepietowski (ORCID: https://orcid.org/0000-0003-0766-6342)
- Hadar Lev‐Tov (ORCID: https://orcid.org/0000-0001-6223-7001)
- Hideki Fujita (ORCID: https://orcid.org/0000-0001-8657-0618)
- Kenzo Takahashi
- Alice B. Gottlieb
- Tae Young Oh
- Marie-Hélène Saintmard
Institutions
- Nihon University (JP)
- University of North Carolina at Chapel Hill (US)
- Wrocław University of Science and Technology (PL)
- University of Miami (US)
- Emory University (US)
- University of Washington (US)
- Liverpool Hospital (AU)
- Military Hospital (PK)
- Erasmus MC (NL)
- University of the Ryukyus (JP)
- Southwestern Medical Center (US)
- UCB Pharma (France) (FR)
- Ingham Institute (AU)
- Hidradenitis Suppurativa Foundation (US)
- Southwestern Medical Center (US)
- AGH University of Krakow (PL)
- Cardiff University (GB)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Pain and Therapy
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1007/s40122-025-00779-7
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- National Eczema Association
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Celgene
- Regeneron Pharmaceuticals
- Taiho Pharmaceutical
- Les Laboratories Pierre Fabre
- Dermira
- Kiniksa Pharmaceuticals
- Torii Pharmaceutical
- Incyte
- Kaken Pharmaceutical
- Ortho Dermatologics
- Galderma
- Sun Pharma
- InflaRx
- LEO Pharma
- Genentech
- Sanofi Genzyme
- Cilag